TABLE 7

Mean fractional reductions in PCV and numbers of patients whose reductions in PCV were >20% or >25% compared to the value at admission by treatment group

Treatment groupDay 0–3Day 0–7Day 0–14
Mean % (SD)% (no. positive/total no.) of patients with PCV reduction:Mean % (SD)% (no. positive/total no.) of patients with PCV reduction:Mean % (SD)% (no. positive/total no.) of patients with PCV reduction:
>20%>25%>20%>25%>20%>25%
AA10.0 (8.2)12.4 (28/226)6.2 (14/226)10.3 (8.2)12.8 (29/226)6.6 (15/226)10.4 (8.2)12.8 (29/226)6.6 (15/226)
AL9.0 (8.4)11.8 (27/228)4.4 (10/228)9.4 (8.4)11.8 (27/228)4.4 (10/228)9.7 (8.7)12.7 (29/228)4.8 (11/228)
DP9.3 (7.9)9.7 (22/228)5.7 (13/228)10.0 (8.2)12.7 (29/199)6.1 (14/228)10.2 (8.2)13.2 (30/228)6.6 (15/228)
Total9.4 (8.1)11.3 (77/682)5.4 (37/682)9.9 (8.3)12.5 (85/682)5.7 (39/682)10.1 (8.3)12.9 (88/682)6.0 (41/682)
P value0.410.620.680.510.940.550.650.990.65